Visa time limits on foreign Ph.D. students and postdocs will harm U.S. science, experts warn
admin In mid-July, the Department of Homeland Security (DHS) announced a final rule that will fundamentally...
Health
Racial Disparities Persist in PMOS and the Evolving Landscape of Global Health Challenges.
The landscape of gynecological health is undergoing a seismic shift, yet long-standing inequities continue to...
Preliminary trial results suggest a path to a safer Alzheimer’s treatment
In a blinded analysis that pooled safety data from patients receiving various doses of PMN310...
FDA Refutes Capricor Therapeutics’ Claims of Success in Pivotal Duchenne Muscular Dystrophy Trial.
The Food and Drug Administration said Monday that Capricor Therapeutics’ stem cell treatment for Duchenne...
Pharmalittle: We’re reading about a U.S. peptide panel’s votes, Amgen scuffling with the FDA, and more
On Friday, an FDA advisory panel concluded a pivotal two-day session that could redefine the...
Sarepta names Michael Severino, former Tessera CEO, as new chief executive
The transition marks the end of the Ingram era, a period defined by Sarepta’s transformation...
HIV resurgence is feared as global funding to combat the disease falls 18%
Overall, government funding declined by more than $1.5 billion to $7.3 billion in 2025 —...
Pharma’s drug spending deflection
To understand the current friction between the Pharmaceutical Research and Manufacturers of America (PhRMA) and...
FDA Panel Backs Peptide Compounding Amidst Record-Breaking Measles Outbreaks and Rising Foodborne Illness Concerns
The landscape of American public health is currently navigating a complex intersection of regulatory shifts,...
Pharmalot Coming and Going: Rigel Pharmaceuticals Taps Alison Hannah as New Chief Medical Officer.
The leadership carousel in the biotechnology sector continues to spin at a rapid clip, and...
